First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report) shares hit a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 1,723.20 ($21.04) and last traded at GBX 1,723.20 ($21.04), with a volume of 519 shares changing hands. The stock had previously closed at GBX 1,702.60 ($20.79).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Performance
The stock has a market capitalization of £5.20 billion and a price-to-earnings ratio of -1,598.91. The company has a quick ratio of 9.27, a current ratio of 9.42 and a debt-to-equity ratio of 0.04. The company has a 50 day simple moving average of GBX 1,656.09 and a 200-day simple moving average of GBX 1,593.16.
About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
See Also
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Why Invest in 5G? How to Invest in 5G Stocks
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- How to Use Stock Screeners to Find Stocks
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.
